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ABSTRACT 
 Glucose homeostasis is vital to mammalian functioning and depends on 
the ability of skeletal muscle and adipose cells to translocate the GLUT4 glucose 
transporter to the plasma membrane in response to insulin stimulation. The 
GLUT4 transporter traffics in insulin-responsive vesicles (IRVs) that also 
incorporate sortilin as a major protein constituent.  Another protein, AS160  (Akt 
substrate of 160kD, a Rab GTPase) is thought to maintain the intracellular 
localization of the IRVs in the absence of insulin.  Previous studies have shown 
that sortilin is induced upon differentiation of pre-adipocytes to adipocytes and 
plays the key role in the formation of the IRVs. We have found that ectopic 
expression of GLUT4 in undifferentiated pre-adipocytes does not lead to its 
marked translocation to the plasma membrane upon insulin stimulation.  On the 
contrary, sortilin expressed in undifferentiated pre-adipocytes translocated to the 
plasma membrane in response to insulin.  Moreover, upon co-expression with 
GLUT4, sortilin dramatically increased insulin responsiveness of GLUT4 to the 
levels observed in fully differentiated adipocytes.  Thus, sortilin may represent 
the key component of the IRVs that is responsible not only for vesicle formation, 
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but for their insulin responsiveness as well. Our experiments also show that 
undifferentiated pre-adipocytes express little AS160 and lack a mechanism for 
the full intracellular retention of GLUT4.  The latter can be achieved by ectopic 
expression of AS160, despite its limited co-localization with GLUT4 or sortilin. 
Mutant AS160 that cannot be phosphorylated by Akt does not allow GLUT4 to 
translocate to the plasma membrane in response to insulin but does provide 
basal retention of GLUT4, showing that AS160 is a major component of basal 
retention. 
Because free fatty acids are elevated in obesity and associated with 
insulin resistance, we studied the effects of palmitate on insulin signaling. 
Palmitate decreased phosphorylation of the insulin-signaling molecule Akt and 
attenuated the ability of adipocytes to take up glucose in response to insulin. We 
have also shown that adipocytes responded to palmitate by forming stress 
granules throughout the cytoplasm. As circulating levels of fatty acids are 
generally increased in obesity, this observation may explain the negative effect of 
obesity on protein expression.  	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I. INTRODUCTION 
A. Obesity and insulin resistance 
Obesity and its associated comorbidities are an extremely prevalent problem 
in the United States.  According to the CDC, the number of children diagnosed as 
obese has more than tripled in the last 30 years and type 2 diabetes is being 
diagnosed at a younger and younger age. A disease once characterized by the 
term “adult-onset” is now being found in as many as half of the newly diagnosed 
cases of pediatric diabetes in addition to the 90-95% of all adult cases that the 
type 2 diagnosis accounts for. The term “metabolic syndrome” arose as a means 
to describe the variety of disorders; insulin resistance, high blood pressure, pro-
inflammatory state, associated with obesity and type 2 diabetes (Grundy et al., 
2004). 
Glucose levels in the blood must be tightly regulated in order for the body 
to properly function. Despite periods of fasting or eating, the concentration of 
glucose in a metabolically normal person stays in a range between 4 and 6mM 
by balancing hepatic glucose production with glucose uptake by the skeletal 
muscle, and to a lesser extent, adipose tissue (reviewed in (Gerich, 2000). After 
a meal, the pancreatic beta cells release insulin, which suppresses glucose 
production in the liver and causes an increase in the rate at which this glucose 
clearance occurs (DeFronzo, 2004). In situations of overconsumption and obesity 
and resulting insulin-resistance, postprandial pancreatic insulin release is no 
longer sufficient to clear glucose from the blood and into the skeletal muscle and 
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adipose tissue where it could be stored as glycogen and triglycerides 
respectively, and the resulting hyperglycemia has many complications (Kahn, 
1998; Shulman, 2000). 
There are many potential causes of insulin resistance but effectively they 
are likely to work together in the development of type 2 diabetes. Aberrant 
signaling, defective GLUT4 translocation, decreased secretion of insulin 
sensitizing adipokines, increased levels of counter-regulatory adipokines, may all 
lead to decreased insulin responsiveness and the pathological state. At what 
point these mechanisms are linked is currently unknown. 
B. CHAPTER 1 
1. Glucose transporters 
Glucose cannot cross cell membranes and must be transported via an 
ATP-independent, facilitative transporter. These proteins, called GLUT proteins 
(Pilch, 1990), were identified in 1985 (Mueckler et al., 1985) and found to be 
ubiquitously expressed. Part of the Major Facilitator Superfamily (MFS), GLUTs 
belong to the smaller sugar porter (SP) subfamily. Each member of this subfamily 
from bacteria, archaea and eukarya, contain 12 transmembrane spanning 
segments and transport a range of sugar substrates (Pao et al., 1998).  
The representative example of a sugar porter is the E. coli D-xylose: H+ 
symporter XylE, which shares 27-30% sequence identity and 47-51% similarities 
to GLUTs 1-4 (Sun et al., 2012). Recently a detailed investigation of the crystal 
structure of XylE was conducted and it was determined that the transporter exists 
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in an outward-facing conformation where it is able to trap its substrate, D-xylose, 
in its transmembrane domains. XylE then undergoes a small conformational 
change in its open structure, favoring a more closed, ligand-bound conformation 
(Sooriyaarachchi et al., 2010). XylE was also shown to bind D-glucose with 
similar dissociation constant to D-xylose. The eight residues responsible for 
recognizing and hydrogen bonding D-xylose to XylE are also involved in XylE 
binding to D-glucose and 6 of these residues are identical in the substrate-
binding domains of GLUTs 1-4 (Sun et al., 2012). Based on this homology, the 
structure of GLUT1 has been predicted and shown in Figure 1. 
There are 14 members of the GLUT family that are composed of 
approximately 500 amino acids each and all contain 12 transmembrane α helix 
domains with both carboxy and N termini in the cytosol, but each transporter has 
a unique expression pattern (Figure 2) (Thorens and Mueckler, 2010). GLUTs 
are facilitative uniporters, glucose binds to the transporter outside the cell 
inducing a conformational change allowing it to move to the interior. 
GLUT1 was the first of these family members to be sequenced and cloned 
from HepG2 cells in 1985 (Mueckler et al., 1985). It is ubiquitously expressed but 
at its highest levels in erythrocytes and is important for transporting glucose 
across the blood-brain barrier (Zhang and Ismail-Beigi, 1998). This is a direct 
contrast to its later-cloned family members who have tissue distinct expression 
patterns. GLUT2 is expressed in pancreatic β cells and the basolateral 
membranes of intestinal and kidney epithelial cells and hepatocytes. A lack of 
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GLUT2 in the pancreatic β cells leads to a loss of ability to secrete insulin 
(reviewed in (Thorens and Mueckler, 2010). GLUT3 is expressed in the brain in 
humans and rodents and at lower levels in the placenta, heart, liver and kidney in 
humans (Shepherd et al., 1992; Haber et al., 1993; Nagamatsu et al., 1994) 
GLUT5 is a fructose transporter that has no ability to actually transport glucose or 
galactose and is mainly found in the small intestine and testes in humans 
(Douard and Ferraris, 2008). 
Despite some sequence homology with its ubiquitously expressed cousin 
GLUT1, the first luminal loop of GLUT4, particular residues in its amino terminus, 
and also dileucine and acidic motifs in its carboxy terminus confer its unique 
trafficking pattern through the Trans Golgi Network (TGN) and the recycling 
endosomes (Holman and Sandoval, 2001; Kim and Kandror, 2012). GLUT4 is 
the main transporter responsible for clearing blood glucose in response to insulin.  
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Figure 1. Predicted structure of GLUT proteins based on sequence 
homology to XylE E. coli D-xylose transporter (Sun et al., 2012) 
a. The GLUT1 transporter is predicted to have an outward-facing, partly occluded 
ligand-binding site like the XylE transporter. Residues that are invariant in GLUT1 
and XylE are shown in magenta and conserved residues are in green. 
b. The structure of XylE bound to D-glucose (as represented by black ball and 
stick model). Hydrogen bonds are illustrated in red and the invariant residues 
between XylE and GLUT1-4 are shown in green.  
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Figure 2. Structure of GLUT protein family (Bryant et al., 2002) 
The GLUT family of sugar transporters all have 12 transmembrane 
domains and have both the amino and carboxy termini in the cytoplasm. This 
diagram highlights in purple the sequence homology between GLUT4, the main 
insulin responsive glucose transporter, and GLUT1, another ubiquitously 
expressed family member. The residues that are unique to GLUT4, some of 
which confer its unique trafficking properties (first luminal loop, carboxy terminus, 
amino terminus in particular) are shown in red.  
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The GLUT4 transporter was identified (James et al., 1988) and cloned in 
1989 (James et al., 1988; Birnbaum, 1989; James et al., 1989) and since then 
has been the focus of much research due to its insulin responsive nature and the 
fact that it is found exclusively in adipose and skeletal muscle tissue and some 
neuronal cells (Bogan, 2012). Though adipose tissue contributes less to glucose 
clearance (5-15%), both adipose tissue and skeletal muscle tissue have 
important roles in maintenance of glucose homeostasis as evidenced by tissue 
specific GLUT4 knockout studies. Adipose tissue redistributes GLUT4 in 
response to insulin so when GLUT4 levels are drastically reduced in adipose 
tissue mice develop glucose intolerance and fasting hyperglycemia (Abel et al., 
2001; Carvalho et al., 2005; Bogan, 2012). When GLUT4 is selectively disrupted 
in muscle, insulin resistance exists at similar severity to the adipose ablation 
(Zisman et al., 2000; Abel et al., 2001). Interestingly, the insulin resistance 
occurring due to muscle ablation of GLUT4 can be effectively reversed by 
overexpressing GLUT4 in the adipose tissue, suggesting that the role of adipose 
tissue goes beyond the scope of its role in glucose clearance (Carvalho et al., 
2005). Double knockout of GLUT4 in adipose and skeletal muscle results in an 
insulin resistant state comparable to either single tissue depletion alone. 
In the skeletal muscle of patients who are obese or diabetic, the level of 
GLUT4 mRNA and protein is unchanged as compared to control mice and 
humans, however insulin signaling is defective (Goodyear et al., 1995; Shepherd 
and Kahn, 1999). This leads to a blunted ability of GLUT4 to traffic in response to 
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the stimulus of insulin and subsequently clear glucose from the blood (Zierath et 
al., 1996). However, it is controversial how much direct impact insulin signaling 
has on glucose uptake (see 4. Insulin Signaling). Levels of GLUT4 mRNA are 
significantly decreased in the adipose tissue of diabetic and obese patients 
(Shepherd and Kahn, 1999). Overexpressing GLUT4 selectively in adipose 
tissue leads to improved total glucose clearance in mice, pointing to its significant 
role in whole body glucose homeostasis (Shepherd et al., 1993). 
In addition to being able to increase the exocytosis of GLUT4 in response 
to insulin, cells must also be able retain GLUT4 in the absence of stimulus. 
Maintaining GLUT4 intracellularly allows the cells to dramatically increase the 
levels of GLUT4 at the plasma membrane in response to insulin. In adipose and 
skeletal muscle tissue, GLUT4 moves from the intracellular space to the plasma 
membrane in specialized vesicles known as Insulin Responsive Vesicles (IRVs).  
  2. Insulin Responsive Vesicles (IRVs) 
 
In the absence of insulin stimulation only 5% of the GLUT4 in an adipocyte 
is present at the plasma membrane, the rest of the protein being localized to 
intracellular vesicles. Some of this intracellularly sequestered GLUT4 is 
maintained in larger vesicles representing the endosome or trans-golgi-network 
but most of the protein is present in much smaller vesicles, aptly name the Insulin 
Responsive Vesicles (IRVs) (Figure 3) (Zorzano et al., 1989; Kandror et al., 
1995; Zhou et al., 1998; Kupriyanova et al., 2002). 
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IRVs are a 60-80S specialized vesicular population present in adipocytes 
and skeletal muscle cells that respond robustly to insulin stimulation and are 
compositionally identical in the two cell types (Kandror et al., 1995). These 
vesicles are a true, unique vesicular compartment that can be isolated and 
analyzed from adipocytes and can be reconstituted in a cell-free system with the 
appropriate components present (Kupriyanova et al., 2002; Xu and Kandror, 
2002). In pre-adipocytes lacking these specific structures, GLUT4 exists in a 
larger 150nm vesicular population that does not respond to insulin but rather 
exhibits trafficking patterns that represent typical endosomal recycling.  
Specific coat proteins exist in eukaryotic cells to participate in the targeting 
of proteins from on organelle to another. Vesicles bud off of donor compartments 
and transfer to acceptors with an intricate assembly of coat proteins around the 
cargo inside. IRVs specifically require clathrin coats and golgi-localized, γ-ear-
containing, Arf-binding proteins or GGAs for vesicle assembly (Robinson et al., 
1992; Abel et al., 2001; Xu and Kandror, 2002; Li and Kandror, 2005). 
     a. Clathrin and its adaptors 
The clathrin protein complex is a triskelion made up of three heavy and 
three light clathrin chain. These chains come together to form three legs of the 
triskelion, each leg joined at its midpoint (Unanue et al., 1981; Ungewickell and 
Branton, 1981). The resulting coat is bound to vesicles by adaptor proteins. 
Adaptor proteins 1-4 (AP1-4) were identified as the first group of proteins to 
mediate the interaction between clathrin-coated vesicles (CCVs) and their 
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contents. These proteins are heterotetramers that link clathrin to the membrane 
underneath it by interaction with phosphotidylinositols, specifically PI (4,5) P2 or 
PI4P. The AP proteins all share two heavy subunits of around 100kDa (γ/β1, α/ 
β2, δ/ β3,ε/ β4), one medium subunit of around 50kDa (µ1-µ4) and one small 
subunit of about 20kDa (σ1-σ4) (Barois and Bakke, 2005). The medium subunits 
are those responsible for recognition of the target protein’s tyrosine-based sorting 
signals YXXΦ in its cytoplasmic tail (Ohno et al., 1998). Di-leucine sorting signals 
are recognized via the β subunits or the medium, µ, subunits of the APs 
(Rapoport et al., 1998) (Hofmann et al., 1999) 
AP2 exists on the endocytic branch of CCV trafficking and mediates the 
intake of cargo from the plasma membrane (Boucrot et al., 2010). AP-1, 3 and 4 
are present in CCVs originating from the TGN and endosomal compartments and 
involved in the formation of vesicles at these locations. AP-1 is mainly 
responsible for sorting in the TGN (Stamnes and Rothman, 1993; Barois and 
Bakke, 2005; Chapuy et al., 2008).  
AP complexes connect clathrin to its target but require another level of 
regulation. ADP-ribosylation factor (ARF) proteins are GTP-binding proteins that 
toggle between a GDP and GTP bound state and recruit AP-1, 3 and 4. They 
initiate the assembly of CCVs and acts as a dock, ultimately mediating the 
interaction between AP-1 and Golgi membranes (Stamnes and Rothman, 1993; 
Zhu et al., 1999). 
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GGAs, γ-ear-containing, Arf-binding proteins, are a clathrin adaptor 
protein family that are ubiquitously expressed and specifically isoforms 1,2 and 3 
are found in mammalian cells. These proteins were discovered in a search for 
proteins related to AP components. They have a carboxy-terminal domain that is 
homologous to that of the 100-200 amino acid “ear” domain that is in the carboxy 
terminus of the γ subunit of AP-1 (Hirst et al., 2000). However, there exists no 
sequence homology in the amino termini of these proteins. The amino terminus 
of all GGA proteins contains a VHS (vps-27 hrs stam) domain. The VHS domain 
recognizes and interacts with the sorting signal DXXLL domain in the cytoplasmic 
tails of proteins such as mannose-6-phosphate receptors and sortilin (Nielsen et 
al., 2001; Puertollano et al., 2001a; Takatsu et al., 2001). 
GGAs do not directly interact with AP-1 but rather associate with the TGN 
and interact with Arf proteins via the GAT domain to recruit clathrin coats 
(Dell'Angelica et al., 2000; Puertollano et al., 2001b). GGAs 1-3 are found in 3T3-
L1s throughout all of differentiation from preadipocytes to adipocytes.  Li et al 
showed in 2005 through immunoprecipitation with the IF8 GLUT4 antibody that 
GGA2 colocalizes with GLUT4 in vitro (Li and Kandror, 2005).  
Immunofluorescent analysis also showed significant colocalization of 
GGA2 and GLUT4 in the TGN and endosomes. This interaction of GGA with the 
IRV is mediated through its VHS domain (Nielsen et al., 2001; Takatsu et al., 
2001; Li and Kandror, 2005). GLUT4 does not contain the DXXLL domain and 
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the actual IRV binding partner for GGA2 was found to be sortilin (Nielsen et al., 
2001; Li and Kandror, 2005; Willnow et al., 2008).  
     b. Differentiation of 3T3-L1 cells 
The 3T3-L1 cell line can be induced with a cocktail of dexamethasone, 3-
isobutyl-1-methylxanthine, fetal bovine serum and insulin to differentiation from a 
fibroblast phenotype to a mature adipocyte (Figure 3) (Green and Meuth, 1974). 
The model is commonly used to study GLUT4 trafficking as it has been shown to 
have many of the characteristics of primary adipocytes. These cells acquire 
insulin responsiveness upon differentiation (Rubin et al., 1977). The IRV was 
shown to be formed as sortilin becomes expressed around Day 3 of 
differentiation, and sortilin has since been shown to be a significant player in 
vesicle formation and responsiveness (Shi and Kandror, 2005). GLUT4 becomes 
expressed the following day and is included in the vesicle. 
     c. Protein Composition of the IRVs 
In addition to GLUT4, IRVs contain several other fairly well characterized 
proteins including Insulin Responsive Aminopeptidase (IRAP), sortilin, low 
density lipoprotein receptor-related protein 1 (LRP1), secretory carrier membrane 
proteins (SCAMPs) and vesicle-associated membrane proteins (VAMPs). The 
protein components of these vesicles were identified by isolating the vesicles 
themselves with a GLUT4 antibody, 1F8 and analyzing the contents by mass 
spectrometry and Western blotting (Kandror et al., 1995; Jedrychowski et al., 
2010).  It has been suggested that one or more components of the IRV must be 
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responsible for insulin responsiveness and also for the basal retention of GLUT4 
vesicles. It is important to note that IRVs do not contain cellugyrin (Kupriyanova 
and Kandror, 2000), a protein localized in other intracellular transport vesicles 
(see section 3 below). 
i. IRAP 
Insulin-regulated aminopeptidase (IRAP) was identified as a 160kd protein 
present in GLUT4 containing vesicles and also shown to have the same 
trafficking pattern as GLUT4 itself (Kandror and Pilch, 1994; Kandror et al., 1994; 
Keller et al., 1995). Also called vp165 or gp160, IRAP is a type II transmembrane 
protein with a large extracellular aminopeptidase domain at its carboxy terminus 
and an amino terminal luminal domain by which it interacts with GLUT4 in the 
IRVs (Shi et al., 2008). IRAP is expressed in many cell types but as pertaining to 
this study, it is expressed in skeletal muscle and adipose tissue (Keller et al., 
1995). It is more abundant in IRVs than GLUT4 at a ratio of approximately 2:1. 
(Kupriyanova et al., 2002).  
Despite sequence homology to aminopeptidases A and N, which are 
constituitively present at the plasma membrane IRAP, like GLUT4, is basally 
sequestered intracellularly in adipocytes (Ross et al., 1998). This distribution 
means that IRAP only has access to its substrates upon stimulation with insulin. 
Upon this insulin stimulation, IRAP also redistributes to the plasma membrane 
(Ross et al., 1996). 	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Figure 3. Differentiation of 3T3-L1 cells 
 3T3-L1 pre-adipocytes are grown to confluency and a differentiation 
cocktail of 0.5mM 3-isobutyl-1-methlxanthine, 1 uM dexamethasone and 167nM 
insulin, 2uM troglitazone is added to the cells 48 hours later to induce the cells to 
differentiate into mature adipocytes. 
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There are 29 specific amino acids in the cytoplasmic domain of IRAP that 
regulate this unique trafficking pattern, making it different from other 
aminopeptidases (Johnson et al., 2001). DED (64-66) and LL (76,77) are motifs 
that regulate recycling and contribute, along with MI (15,16) are responsible for 
the rapid internalization and slow recycling pattern of GLUT4. 
The physiological significance of IRAP was demonstrated by Keller et al. 
in 2002 by the disruption of the IRAP gene in mice. Though the mice had normal 
body weight throughout their lives and were able to respond relatively normally in 
glucose and insulin tolerance tests, the levels of GLUT4 protein (but not GLUT1) 
in muscle and fat were decreased in mice without IRAP (Keller et al., 2002). The 
mice in turn had decreased glucose uptake. Its exact role in GLUT4 trafficking 
remains elusive but interestingly, IRAP protein is decreased upon GLUT4 
knockout in muscle but increased in GLUT4 deficient adipocytes (Jiang et al., 
2001). In the GLUT4 deficient adipocyte, IRAP was shown to recycle 
constituitively rather than responding to insulin as it does when GLUT4 is present 
(Jiang et al., 2001). However, another study using NIH-3T3 cells (which lack 
GLUT4) expressing the transcription factor peroxisome proliferator-activated 
receptor γ (PPARγ) shows that these cells differentiate and that the IRAP in 
these cells is capable of responding to insulin in the absence of GLUT4 (Gross et 
al., 2004). 
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ii. Sortilin 
Sortilin, also named neurotensin receptor 3 was first discovered in the 
brain by binding to receptor associated protein (RAP), an ER/ Golgi protein 
involved in sorting members of the low density lipoprotein receptor family of 
proteins (Zsurger et al., 1994; Petersen et al., 1997). It also binds to neurotensin  
and prosaposin (Zsurger et al., 1994; Lefrancois et al., 2003). Sortilin itself does 
not bear resemblance to other members of this family of lipoprotein receptors. 
Sortilin is a 110-kDa Type I integral membrane protein (also called gp110) 
that is homologous to the yeast vacuolar protein sorting (Vps10p) family of 
sorting receptors. This family also includes SorLA and SorCS1-3. All family 
members share a large N-terminal domain that contains the Vps10p domain, a 
transmembrane domain and the carboxy-terminal cytoplasmic domain (Figure 4) 
(Petersen et al., 1997; Morris et al., 1998).  
The Vps10p domain is 700 amino acids, cysteine-rich, and makes up the 
entire extracellular domain of sortilin (Westergaard et al., 2004). It contains a 
conserved furin cleavage site [RX(R/K) R] where the propeptide is removed for 
the formation of mature human sortilin in the late Golgi compartments (Petersen 
et al., 1997). 
The cytoplasmic tail of sortilin contains motifs similar to those of the cation 
independent mannose 6-phosphate receptor (CI-MPR). The acidic dileucine motif 
in the acidic DEDLL motif of sortilin is identical to that of the CI-MPR and 
mediates interactions between sortilin and the Golgi-associated γ -ear containing 
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Arf-binding (GGA) adaptor proteins, specifically interacting with the VHS domain 
(Nielsen et al., 2001). As mentioned earlier, GGAs are known to be necessary for 
biogenesis of the IRVs and it may be that the GGA/sortilin interaction is 
moderating this vesicle formation (Watson et al., 2004). A dominant negative 
form of GGA results in significantly decreased insulin-stimulated glucose uptake 
in 3T3-L1 adipocytes pointing to the importance of this interaction (Li and 
Kandror, 2005). It has also been shown that sortilin can traffic to the plasma 
membrane in response to insulin but to a lesser extent than GLUT4 (Kandror and 
Pilch, 1998).  
Sortilin has many functions that are cell-type specific. It can bind many 
ligands and function in intracellular sorting, endocytosis, and targeting enzymes 
to the lysosomes (reviewed in (Ni et al., 2006). Sortilin functions in a tissue-
specific manner to mediate transport in many cell types including the insulin 
responsive fat and skeletal muscle, but is also present in neurons (Willnow et al., 
2008; Braulke and Bonifacino, 2009). Sortilin colocalizes in clathrin-coated 
vesicles with mannose-6-phosohate receptors (MPRs) where it acts as a 
recycling receptor to transport lysosomal enzymes from the TGN to the 
endosomes and back to the TGN (Mari et al., 2008). However, sortilin has many 
diverse roles and has been shown to interact with and transport soluble amyloid 
precursor protein (sAPP) and lysosomal enzymes like acid sphingomyelinase 
(ASM), to the lysosome itself (Ni and Morales, 2006; Gustafsen et al., 2013). 
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Sortilin is also involved in hepatic lipoprotein export from the TGN, increasing 
plasma LDL levels (Kjolby et al., 2010). 
Sortilin was found to be a major component of the IRV in primary rat 
adipocytes. It is induced in 3T3-L1’s upon differentiation one day before Glut4 
begins to express (Days 3 and 4 respectively) (Lin et al., 1997; Morris et al., 
1998). It was shown that sortilin is required for the biogenesis of an insulin 
responsive compartment in adipocytes and that without it GLUT4 loses its ability 
to efficiently translocate to the plasma membrane (Shi and Kandror, 2005; Ariga 
et al., 2008). Sortilin stabilizes ectopically expressed GLUT4 protein in 
preadipocytes where it is rapidly degraded otherwise (Shi and Kandror, 2005; Liu 
et al., 2007). In turn, knockdown of sortilin decreases the level of insulin-
stimulated glucose uptake (Shi and Kandror, 2005). 
Using quantum dot-based single-molecule imaging, Hatakeyama et. al 
closely examined the trafficking properties of individual molecules of GLUT4 in 
undifferentiated cells as compared to differentiated cells (Hatakeyama and 
Kanzaki, 2011). This group showed that the presence of sortilin, through 
differentiation or exogenous expression, greatly restricts the movement of 
GLUT4 in the absence of insulin. They also used siRNA to knockdown sortilin in 
a fully differentiated adipocyte and showed the accelerated movement of GLUT4 
and a decrease in responsiveness to insulin. Since it was known that the 
cytoplasmic tail of sortilin was involved in its Golgi to endosome transport (Shi 
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and Kandror, 2007), two critical residues C783 or F787LV, were mutated and the 
ability to statically retain GLUT4 was abolished. 
The interaction between GLUT4 and sortilin occurs luminally in both 
proteins, the first luminal loop of GLUT4 interacting with sortilin’s luminal Vps10p 
domain (Shi and Kandror, 2007). When the luminal domain of sortilin was 
mutated, rendering it unable to interact with GLUT4, sortilin was still able to 
maintain the static behavior of GLUT4 (Hatakeyama and Kanzaki, 2011). Rather 
than actually anchoring GLUT4 intracellularly, sortilin likely recruits GLUT4 to a 
specialized TGN compartment where it is retained until there is insulin stimulation 
(Figure 5) (Hatakeyama and Kanzaki, 2011). Sortilin’s contribution to insulin 
resistance has been examined using ob/ob and db/db mice in addition to 3T3-L1 
adipocytes in culture. The hypothesis was that the disruption in GLUT4 
localization in an insulin resistant state resulted from changes in the levels of 
proteins involved in trafficking GLUT4. Kaddai et. al showed that the levels of 
SORT1 mRNA and correspondingly the sortilin protein, were decreased in white 
adipose tissue and in the skeletal muscle of db/db and ob/ob mice and in the 
white adipose tissue of morbidly obese individuals (Kaddai et al., 2009; Ai et al., 
2012). Knocking down sortilin in adipocytes demonstrates that GLUT4 is less 
effectively incorporated into vesicles and the ability of the cells to take up glucose 
is markedly (two-fold) decreased in the absence of sortilin (Shi and Kandror, 
2005). 
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Figure 4. Domain structure of the Vps10p-D receptors (Hermey, 2009) 
 The Vps10p family of sorting receptors all contain the Vps10p domain and 
the furin cleavage site for removal of the propeptide. Other domains, unique to 
each member, are shown here. 
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Figure 5. Proposed model of functions of sortilin (Hatakeyama and Kanzaki, 
2011) 
After GLUT4 traffics to the plasma membrane in the IRV, it is internalized 
back from the plasma membrane. GLUT4 goes through the early endosome 
compartment to the endosomal recycling compartment and sorted back to the 
TGN with the help of sortilin and a TGN-golgin (golgin 97). GLUT4 is maintained 
in this compartment before it is recruited back into the IRV and released by 
AS160 activation in response to insulin. 
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iii. LRP1 
Low Density Lipoprotein receptor related protein, known as LRP1, was 
discovered as the second member of seven members of the Low Density 
Lipoprotein (LDL) superfamily of receptors (Herz et al., 1988). LRP1, also known 
as CD91 or α2 macroglobulin, is a type 1 transmembrane receptor that is 
ubiquitously expressed and has many functions aside from lipoprotein clearance 
from the blood (Herz et al., 1988; Herz and Strickland, 2001). The variability in its 
endocytic and signaling regulation functions comes from the ability of its ligand 
binding repeats to recognize many ligands including lipoproteins, growth factors, 
etc. (Herz and Strickland, 2001; May et al., 2007). 
LRP1 is one of the most abundant proteins found in the IRV but is found in 
both 3T3-L1 adipocytes and pre-adipocytes (Figure 12) (Corvera et al., 1989; 
Descamps et al., 1993; Ko et al., 2001). It was shown to sediment in the same 
fractions as GLUT4 and IRAP on a sucrose gradient (Zhang et al., 2004; 
Jedrychowski et al., 2010). Its interaction with the other vesicular proteins was 
examined by immunoprecipitation with the IF8 anti-GLUT4 antibody and shown 
that these four major proteins, sortilin, GLUT4, IRAP and LRP1 co-
immunoprecipitate with each other. 
 LRP1 is important for the stability of the other IRV proteins. Depletion of 
LRP1 in adipocytes leads to decreased GLUT4 and sortilin expression and 
subsequently decreased insulin-stimulated glucose uptake (Jedrychowski et al., 
2010). LRP1 also interacts with the Rab GTPase activating protein AS160. 
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3. Cellugyrin-Containing Vesicles 
Within the mature adipocytes and skeletal muscle cells, GLUT4 does not 
reside solely in these IRVs. Another subpopulation of GLUT4 containing vesicles 
exists that does not translocate to the plasma membrane in response to insulin, 
and this population is marked by the presence of cellugyrin (Kupriyanova and 
Kandror, 2000). Cellugyrin is a four transmembrane protein, discovered as a 
homologue to the synapatic vesicle protein synaptogyrin and has been found in 
50-60% of the vesicles that contain Glut4 (Janz and Sudhof, 1998; Kupriyanova 
and Kandror, 2000). Though its exact physiological function is as yet unknown, 
cellugyrin is a marker for the population of GLUT4 containing vesicles that do not 
traffic in response to insulin. Cellugyrin containing vesicles also contain the main 
recycling proteins transferrin receptor, IRAP, sortilin and mannose 6 phosphate 
receptor (Kupriyanova and Kandror, 2000). 
4. Insulin signaling 
Insulin signaling begins when it is released from the pancreatic β-cells and 
a molecule of insulin binds to the external two α subunits of the insulin receptor 
leading to activation of the tyrosine kinase and autophosphorylation of the β 
subunits of the receptor (Herrera and Rosen, 1986; White et al., 1988). This 
leads to activation of the kinase activity of the receptor resulting in the 
phosphorylation of Insulin Receptor Substrate (IRS). Isolated from insulin-treated 
rats, IRS-1 was the first discovered IRS protein, found to be significantly tyrosine 
and serine phosphorylated in response to insulin (Sun et al., 1992). Knockout of 
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IRS-1 in mice leads to growth retardation and mild insulin resistance as 
evidenced by reduced phosphatidylinositol 3-kinase activity, but the knockout 
does not result in the development of the diabetic state due to compensatory 
increased insulin secretion (Tamemoto et al., 1994; Bruning et al., 1997; 
Terauchi et al., 1997). This ability of the mouse to maintain some regulation over 
glucose disposal pointed to a redundancy in signaling pathways and the 
discovery of IRS-2 (Sun et al., 1995).  
IRS-1 and 2 are highly homologous and are both found in adipocytes, 
liver, and skeletal muscle and have some overlapping signaling function. Both 
have a plecktstrin homology domain and phosphotyrosine binding domains in 
their amino termini and though it’s less conserved, they both have many tyrosine 
phosphorylation sites that are recognized by proteins with SH2 domains (Araki et 
al., 1994). Despite the similarities between IRS-1 and IRS-2, IRS-1 expression is 
increased ten-fold upon differentiation into mature human adipocytes whereas 
IRS-2 expression is only increased about two-fold (Pederson and Rondinone, 
2000). The changes in protein expression during differentiation into mature 
adipocytes are significant as this is when the cells acquire insulin 
responsiveness.  
Though IRS-1 -/- mice do not develop diabetes, knockout of IRS-2 in mice 
does result in peripheral insulin resistance and subsequent clinical type 2 
diabetes (Withers et al., 1998; Kubota et al., 2000). This is due to the fact that 
IRS-2 disruption reduces the β-cell mass by half compared to wild type 
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littermates and one-third the mass of the IRS-1 -/- mice (Sun et al., 1995; Withers 
et al., 1998). IRS-1 exerts the majority of its effects in tissues that deal with 
glucose disposal (skeletal muscle) while IRS-2 functions in insulin production 
(pancreatic β-cells) (Sesti et al., 2001; White, 2002). 
Phosphorylated IRS binds to PI3K through two SH2 domains which are 
part of its 85-kDa (p85) regulatory subunit (Hadari et al., 1992; Myers and White, 
1996). This binding activates the catalytic 110-kDa subunit of PI3K. Active PI3K 
forms phosphotidylinositol-3,4,5-triphosphate [PI(3,4,5)P3] from the lipid 
phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2]. By mutating the p85 subunit, 
making PI3K unable to bind the IR, or by using general PI3K inhibitors like 
wortmannin, glucose uptake into adipocytes is inhibited, indicating the necessity 
of PI3K signaling for glucose homeostasis (Hara et al., 1994; Okada et al., 1994; 
Kotani et al., 1995; Myers and White, 1996). Moreover, overexpressing the 
catalytic p110 subunit increases glucose transport in the absence of insulin, 
pointing to its significance in the insulin-signaling pathway (Katagiri et al., 1996). 
Decreased insulin-stimulated PI3K activity is found in states of obesity and 
insulin resistance (Bjornholm et al., 1997; Kim et al., 1999). 
The increase in PI (3,4,5) P3 recruits Akt to the plasma membrane where 
it is phosphorylated and activated by phosphoinositide-dependent protein kinase 
1 (PDK1) which then activates Akt. Akt, also called protein kinase B or PKB, is a 
serine/threonine kinase with three isoforms, Akt 1-3. Akt was originally identified 
as an oncogene amplified in primary gastric adenocarcinoma in humans. It is 
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phosphorylated on Thr 308 and on Ser 473 by Protein Dependent Kinase 1 
(PDK1) and mammalian target of rapamycin 2 (mTORC2) for complete activation 
(Alessi et al., 1996; Sarbassov et al., 2005). Akt2 specifically is found in 
adipocytes and its phosphorylation is required for GLUT4 translocation. A 
constituitively active mutant form of Akt2 can enhance GLUT4 translocation 
without insulin (Okada et al., 1994; Kohn et al., 1998). When Thr 308 and Ser 
473, along with a residue in the catalytic region of Akt, are mutated to alanines, 
GLUT4 translocation is markedly decreased (Wang et al., 1999). 
Akt 2 is enriched in insulin responsive tissues and is the main insulin 
signaling pathway substrate responsible for GLUT4 trafficking (Huang and 
Czech, 2007). It was shown by sucrose velocity gradient centrifugation to co-
localize with GLUT4 and it is present in GSVs (Calera et al., 1998; Kupriyanova 
and Kandror, 1999). Because whole body ablation of Akt2 in mice leads to insulin 
resistance and impaired glucose tolerance, it can be concluded that it is part of 
the insulin signaling pathway that is required for glucose homeostasis (Cho et al., 
2001). More recently, the role of insulin signaling through IRS1 and subsequent 
Akt activation has been shown to have a potentially smaller role in insulin 
resistance than was previously determined. Insulin-stimulated Akt 
phosphorylation is often used as a biochemical readout of insulin signaling, 
however, the amount of phosphorylation was shown to not directly correspond to 
the functional readout of GLUT4 translocation (Hoehn et al., 2008). 
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An important downstream target of Akt, Akt substrate 160 (AS160 or 
TBC1D4) is a Rab GTPase activating protein that was discovered in a screen for 
substrates of Akt through immunoprecipitation with the phospho (Ser/Thr) Akt 
(PAS) antibody. Its regulation may be involved in GLUT4 trafficking (Kane et al., 
2002). Due to its position as an Akt substrate and its presence in GSVs, AS160 
may be the protein connecting insulin signaling with GLUT4 trafficking (Bogan, 
2012). AS160 is known to associate with GLUT4 containing vesicles in the 
absence of insulin (Peck et al., 2006) and to dissociate upon insulin stimulation 
(Larance et al., 2005). It is hypothesized that AS160 was involved in statically 
maintaining GLUT4 intracellularly in the absence of insulin (Muretta et al., 2008).   
Evidence for AS160s involvement starts with the six putative sites for 
phosphorylation by Akt, five of which exist in the RXRXXS/T motif recognized by 
Akt and are as follows, RSRCSS318V, RRRHAS341A, RGRLGS588M, 
RRRAHT642F, RKRTSS751T . These five are phosphorylated in response to 
insulin stimulation (Figure 6) (Kane et al., 2002; Sano et al., 2003). If four of 
these sites (Serine 308, Serine 588, Threonine 642 and Serine 751) are mutated 
to alanines, creating what will be referred to as the AS160-4P mutant, the fold 
change in GLUT4 traffic to the plasma in basal vs insulin stimulated cells is 
dramatically reduced (Sano et al., 2003). AS160 was shown to be a critical 
regulator of GLUT4 translocation as, despite changes in upstream signaling 
caused by insulin resistance, AS160 remains able to be phosphorylated normally 
in response to both insulin and PDGF (Hoehn et al., 2008). 
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Figure 6. Schematic Diagram of human AS160 (Sano et al., 2003) 
 The sites of phosphorylation in an insulin treated sample were determined 
using targeted ion MS/MS. Also shown are the two phosphotyrosine binding 
domains and the domain with Rab GAP activity. 
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Depleting cells of AS160 altogether using shRNA results in a redistribution of 
GLUT4 from the intracellular space to the plasma membrane (Eguez et al., 2005; 
Larance et al., 2005). Though AS160 knockdown does result in an increase in 
basal GLUT4 at the plasma membrane, this flux is not as dramatic as an insulin 
response, indicating an incomplete release of the intracellular stores (Eguez et 
al., 2005; Larance et al., 2005; Brewer et al., 2011). Additionally, in cases of 
AS160 and IRAP depletion together the effects of increased plasma membrane 
GLUT4 are additive, which points to the involvement of other proteins in 
intracellular retention (Jordens et al., 2010). 
Rab proteins are a family of monomeric small GTPases that are 
distributed throughout the cell and shown to regulate intracellular transport by 
toggling between the active GTP and inactive GDP bound forms. They are 
involved specifically in vesicle tethering and docking. Rabs 2, 4, 8, 10, 11 and 14 
have been found in association with GLUT4-containing vesicles however, not all 
are involved in the insulin responsive trafficking of GLUT4 (Larance et al., 2005; 
Miinea et al., 2005; Kaddai et al., 2008; Chen et al., 2012). Rab 11 has 
involvement in recycling endosomes and plasma membrane-Golgi traffic, Rab 4 
is involved in early/recycling endosomes, and Rab 10 is involved in traffic from 
the TGN (Zerial and McBride, 2001). Rab10 also has a newly emerging role in 
regulating the morphology of the endoplasmic reticulum (English and Voeltz, 
2012). Localized to the leading edge of ER tubules, Rab10 regulated the 
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dynamic extension and fusion of the tubule structures (Chang and Blackstone, 
2012; English and Voeltz, 2012) 
The Rab 10 protein may represent a specific target of the GTPase activity 
of AS160. It is found in adipocytes and shown to be required for GLUT4 
translocation (Sano et al., 2007; Sano et al., 2011). One model of AS160 function 
is that, as a Rab GTPase, AS160 activity keeps Rab10 in its inactive, GDP-
bound form. Upon insulin stimulation when AS160 is phosphorylated, its GAP 
activity would be inhibited and GTP-bound Rab is actively able to participate in 
GLUT4 translocation (Sano et al., 2003; Sano et al., 2007). This model is 
supported by the inhibited plasma membrane translocation of Rab10 in cells with 
a constituitively active mutant of AS160 (Chen et al., 2012). Expression of a 
constituitively active mutant form of Rab10, where a leucine is substituted for a 
glutamine at position 68, causes a two-fold increase in the amount of a reporter 
GLUT4 protein at the plasma membrane of basal adipocytes (Sano et al., 2007). 
In contrast, knocking down Rab10 in adipocytes using siRNA cause a 30% 
decrease in the amount of GLUT4 able to redistribute to the plasma membrane in 
response to insulin (Sano et al., 2007). Insulin signaling itself was unaffected by 
the Rab10 knockdown as AS160 and Akt were phosphorylated at the same level 
as control cells. Despite normal differentiation and unaffected levels of 
expression of other Rab proteins (4 and 11), knockdown of Rab10 was sufficient 
to blunt GLUT4 translocation but leave retention unaffected (Sano et al., 2007). 
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Tether containing a UBX domain for Glut4 (TUG) is a 60-kDa putative 
anchoring protein that was discovered while searching for proteins that alter 
GLUT4 distribution (Bogan et al., 2003; Bogan et al., 2012).  By 
immunoprecipitation with a GLUT4 antibody, TUG was shown to interact directly 
with GLUT4. Further analysis showed that this interaction with GLUT4 was 
mediated through the N terminus of TUG (residues 313-376) while its C terminus 
(residues 463-550) is responsible for anchoring in intracellular non-endosomal 
compartments (Bogan et al., 2003). TUG was predicted to function in GLUT4 
retention in the absence of insulin (Bogan et al., 2003; Yu et al., 2007). 
Separating the plasma membrane from the low-density microsomes (LDM) by 
differential centrifugation, GLUT4 and TUG were found to co-sediment in the 
LDM fraction but to a lesser degree in the plasma membrane. GLUT4 massively 
redistributes from the LDM to the plasma membrane in response to insulin while 
TUG remains localized to the LDM. The lack of TUG translocation with insulin 
stimulation suggests dissociation of the TUG-GLUT4 complex upon insulin 
stimulation (Bogan et al., 2003).  
Knockdown of TUG in adipocytes using shRNA points to its importance in 
basal retention. Using both immunofluorescence and differential centrifugation in 
unstimulated adipocytes it was shown that without TUG, GLUT 4 redistributed to 
the plasma membrane. Without being able to sequester GLUT4 basally, cells 
lacking TUG were also unable to increase glucose uptake in response to insulin 
as efficiently as the control cells (∼two fold vs. four increase with insulin) (Yu et 
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al., 2007). This effective blunting of insulin responsiveness was rescued by the 
overexpression of TUG in these cells. 
Due to the fact that TUG is found in both pre-adipocytes and fully 
differentiated adipocytes it is an interesting candidate for participating in GLUT4 
retention as shown by the model in Figure 7. Though undifferentiated pre-
adipocytes are unable to fully retain GLUT4 in the absence of insulin, TUG is a 
viable candidate for the partial tethering of GLUT4.  
  
	  39 
Figure 7. Intracellular GLUT4 trafficking model (Bogan and Kandror, 2010) 
 In the absence of insulin stimulation, GLUT4 is retained in the IRV in the 
perinuclear region through the combined action of TUG, Ubc 9 (and AS160). The 
vesicles are composed of the proteins IRAP, LRP1, VAMP2, and sortilin and are 
formed by the collective action of the adaptors GGA, ACAP1, clathrin coats, and 
phosphatidylinositol 4 phosphate. The TGN and recycling endosomes serve as 
donor membranes for IRVs and sites of GLUT4 trafficking. When the cell is 
stimulated with insulin, the IRV moves to the plasma membrane and fuses with it. 
After fusion, the vesicle proteins are recycled through sorting endosomes and 
returned to the TGN and recycling endosomes to participate in another round of 
stimulation and fusion. 
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C. CHAPTER 2  
1. Acyl-CoA Synthetase  
Elevated levels of circulating free fatty acids are implicated as part of the 
pathology of insulin resistance secondary to obesity (Boden, 1997). Fatty acids 
are processed by acyl-CoA synthetase enzymes that are classified by their 
preferred length of substrate. Acyl-CoA synthetase long chains (ACSL) are the 
enzymes that catalyze the conversion of fatty acids (chains between 12 and 20 
carbons) to acyl-CoA thioesters by the addition of ATP and a CoA group. They 
were first discovered by activity in guinea pig liver (Kornberg and Pricer, 1953) 
and since then the human genes have been cloned (Suzuki et al., 1990). This 
ACSL group has five members, 1, 3, 4, 5, and 6 and each member has different 
splice variants (Soupene and Kuypers, 2008). The cDNA for what was thought to 
be ACSL2 was actually the same as the gene for ACSL1. In a broad sense, the 
long chain Acyl-CoA synthetase enzymes are necessary to the activation of fatty 
acids and this activation can lead to catabolic or synthetic pathways.  
Acyl-CoA synthetase long chain 1 (ACSL1) is predominantly found in the 
liver and adipocytes (Suzuki et al., 1990) but has differential cellular localization 
based on cell type. In the liver it is found in endoplasmic reticulum and 
mitochondrial-associated membranes (Lewin et al., 2001) while in adipocytes 
ACSL1 has been found in association with the plasma membrane (Gargiulo et 
al., 1999), the surface of lipid droplets (Brasaemle et al., 2004) and the IRV 
(Sleeman et al., 1998). It was shown to have activity in the mitochondrial/nuclear 
	  41 
fraction, the high-density microsomes and the low-density microsomes as well as 
the plasma membrane with the fraction possessing the highest levels of activity 
varying due to metabolic states (such as fasting and feeding) (Wang et al., 2004). 
Upon differentiation from pre-adipocytes to adipocytes, acyl-CoA synthetase 
activity increases 100 fold, due to increase in ACSL1 expression (Coleman et al., 
1978; Coleman et al., 2000).  
In adipocytes ACSL1 interacts with fatty acid transport protein 1 (FATP1) 
(Gargiulo et al., 1999) and is speculated to regulate triglyceride synthesis, fatty 
acid esterification and fatty acid influx. More recently however, it seems as if 
ACSL1 has a significant role in transporting fatty acids out of the cell as well 
(Lobo et al., 2009). The idea is that when triacylglycerides (TAG) are broken 
down during lipolysis, free fatty acids are released and ACSL1 reacylates these 
free fatty acids, preventing them from leaving the cell. Supporting this hypothesis, 
when ACSL1 was silenced using shRNA, adipocytes displayed 7-fold increase in 
basal fatty acid efflux and a smaller increase in forskolin-stimulated efflux (Lobo 
et al., 2009). The knockdown cells also display a decrease in AMPK activity and 
insulin-stimulated glucose uptake. The ACSL1 mechanism of action produces 
AMP as a byproduct, increasing the AMP/ATP ratio and this is enough to 
increase activity of AMPK. The knockdown cells have an increase in fatty acids 
which activate downstream kinases (PKCθ to JNK) and lead to an increase in the 
phosphorylation of IRS-1 at Ser 307, inhibiting its interaction with the insulin 
receptor which causes IRS-1 to be degraded and decrease downstream 
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signaling events (Gao et al., 2004). This leads to decreased Akt phosphorylation 
at Ser 308 and a subsequent decrease in insulin-stimulated glucose uptake, 
pointing to the role of ACSL1 in regulation of insulin responsiveness (Lobo et al., 
2009).  
Another important role for ACSL1 in adipocytes could be the requirement 
for activated fatty acids in order to bud vesicles from the Golgi (Glick and 
Rothman, 1987; Pfanner et al., 1989; Ostermann et al., 1993). This combined 
with its association with IRV membranes suggests a role of ACSL1 and acyl-CoA 
in IRV biogenesis (Sleeman et al., 1998). Supporting this data, our lab has 
shown that knockdown of ACSL1 in 3T3-L1 adipocytes leads to a reduction in 
IRVs, reflective of the decrease in GLUT4, sortilin, and IRAP protein levels 
(Huang, 2010).  
     a. ACSL1 and adiponectin, cellular stress through free fatty acids 
Recently, ACSL1 has been shown to modulate the effects of free fatty 
acids in states of obesity. As a major dietary saturated fatty acid, the effects of 
palmitate have been studied extensively. The presence of palmitate correlates 
with lower plasma levels of adiponectin (ACRP30), an insulin-sensitizing 
adipokine (Fernandez-Real et al., 2005) and decreased levels of adiponectin 
mRNA in humans and isolated primary mouse adipose cells (Ruan et al., 2003; 
Bueno et al., 2008). In 3T3-L1 cultured adipocytes, the decrease in adiponectin is 
blunted by the knockdown of ACSL1, showing that this effect of palmitate on 
adiponectin is ACSL1-dependent (Karki et al., 2011).  
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The decrease in secretion of adiponectin may be attributed to stress on 
the endoplasmic reticulum. Supporting this hypothesis, it was recently shown that 
the addition of Tauroursodeoxycholic acid, a compound that alleviates ER stress 
was sufficient to rescue 3T3-L1 adiponectin secretion in diabetic mice and in 
3T3-L1 adipocytes (Zhou et al., 2010). Contrary to this finding, the decrease in 
adiponectin levels occurs much more quickly following palmitate incubation than 
incubation with the ER stress-inducer tunicamycin (Karki et al., 2011). This 
indicates that a mechanism for degradation is in play for decreasing levels of 
adiponectin. Treating cells with the lysosomal inhibitor chloroquine attenuates the 
degradation of adiponectin in response to palmitate treatment, an effect that is 
mediated by targeting by sortilin (Karki et al., 2011). Though the decrease in 
secreted protein is linked to ER stress and regulation at the translational level 
(Zhou et al., 2010) and also increased lysosomal degradation, palmitate 
incubation also decreased adiponectin at the level of mRNA (Karki et al., 2011).  
We examined the relationship between palmitic acid and the formation of 
mammalian stress granules, a marker of cellular stress. Stress granules were 
first characterized in Peruvian tomato plants in response to heat shock, 
accompanied by the induction of heat shock protein 70 which is highly conserved 
in eukaryotes (Kelley and Schlesinger, 1982; Nover et al., 1983). Later 
discovered in mammalian cells stress granules, also called heat shock granules, 
are sites of stalled mRNA translation (Kedersha et al., 1999). Stress granules 
formation is initiated by hyperphosphorylation of the eIF-2α subunit of the pre-
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initiation complex, preventing the 48S pre-initiation complex from forming 
(Kedersha et al., 1999). This phosphorylation event is sufficient to form stress 
granules (Kedersha et al., 1999; Kimball et al., 2003). Aside from the stalled 
polyadenylated mRNA these sites also contain eIF3, components of the 48S pre-
initiation complex, poly-adenlylate binding protein-I, the cytotoxic granule-
associated RNA binding protein TIA-1 and the translation repressor TIAR 
(Kedersha et al., 2002; Kimball et al., 2003). TIA-1 and TIAR are involved in 
signaling that leads to apoptosis (Tian et al., 1991; Kawakami et al., 1992; 
Taupin et al., 1995). TIA-1 is required to target other components of the stress 
granule to these distinct foci in times of cellular stress and a mutated version 
does not allow mRNA to accumulate at these sites in response to stress 
(Kedersha et al., 1999; Kedersha et al., 2000). 
In mammalian cells, stress granules have been demonstrated in response 
to sodium arsenite (a compound that promotes oxidative stress) and heat shock 
in NIH/3T3 fibroblasts and mouse embryonic fibroblasts (Kimball et al., 2003). 
Due to their ability to cause ER stress, fatty acids could potentially stall the 
translation of adiponectin mRNA by forming stress granules as a response to 
decreased initiation of translation.  
D. Thesis Objective 	  
 With the extensive research conducted on GLUT4 and the insulin 
responsive vesicle, the roles of many of the proteins have been elucidated. 
GLUT4, sortilin and IRAP have been characterized as cargo proteins but precise 
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mechanisms of vesicle formation and translocation haven’t become entirely clear. 
Sortilin’s suggested role in insulin responsiveness was further addressed and 
expanded upon by this study. The mechanism of basal GLUT4 retention is an 
important area of study because without maintaining low levels of GLUT4 at the 
plasma membrane in the absence of insulin, cells are unable to upregulate these 
levels in response to insulin. This lack of responsiveness is a marker of insulin 
resistance and type 2 diabetes. We examined the AS160 protein to further 
examine its role in this retention mechanism. 
II. MATERIALS AND METHODS 
A. Reagents 
Troglitazone was purchased from Cayman Chemicals.  Palmitic Acid was 
purchased from CalBiochem. Puromycin and blasticidin were purchased from 
InvivoGen. Fetal bovine serum and Donor bovine serum were purchased from 
Atlanta Biologicals (Lawrenceville, GA). G418, sucrose, Triton-X-100, DTT, 
phenylmetanesulfonylfluoride (PMSF), sodium hydroxide, potassium chloride, 
EGTA, sodium chloride, glycine, Tris, sodium phosphate, and sucrose were 
purchased from American Bioanalytical (Natick, MA). EZ-Link sulfo NHS-SS 
Biotin, EZ-Link NHS biotin, Streptavidin Agarose Resin and the BCA protein 
assay kit were purchased from Pierce (Rockford, IL) 30% acrylamide Proto-gel is 
from National diagnostics (Atlanta, GA). 3H-2-deoxyglucose was purchased from 
Perkin Elmer (Waltham, MA). Lipofectamine 2000, Slowfade Antifade kit, Alexa 
Fluor 488 donkey anti-rabbit IgG (H+L), D-PBS, and trypsin-EDTA (10X) are from 
	  46 
Invitrogen (Carlsbad, CA).  Penicillin-Streptomycin (100X) and DMEM are from 
Cellgro (Manassas, VA). NiNTA agarose resin, mini and maxi prep kits were 
obtained from Qiagen. Anti-Chicken HRP, Anti rabbit IgG, 3-Isobutyl-1-
methylxanthine, 2-deoxyglucose, phosphatase inhibitor cocktail 3, glycerol, 
protease inhibitor cocktail, donkey serum, goat serum, BSA (bovine serum 
albumin), dexamethasone, insulin, magnesium sulfate, magnesium chloride, N-2-
hydroxyethyl piperazine-N’-2 etansulfonic acid (HEPES), cycloheximide, calcium 
chloride, TEMED, digitonin, D-(+)- glucose, N,N,N′,N′-
Tetramethylethylenediamine and Imidazole were obtained from Sigma (St. Louis, 
MO). Precision plus protein kaleidoscope ladder, 0.4cm gap electroporation 
cuvettes and electroporation buffer were obtained from Biorad (Hercules, CA). 
Potassium Hydroxide is from JT Baker (Center Valley, PA). 
B. Antibodies  
Monoclonal anti-mouse myc antibody, polyclonal anti-rabbit myc antibody, 
polyclonal anti-phospho-S6, polyclonal phospho-AS160 antibody were from Cell 
Signaling (Danvers, MA). DyLight 488 goat anti-mouse IgG, cyanine 2 goat anti-
mouse IgG (H+L) and cyanine 3 donkey anti-mouse IgG (H+L) were obtained 
from Jackson ImmunoResearch Labaratory (West Grove, PA). Polyclonal eIF3η 
and LRP1 antibodies were obtained from Santa Cruz. Anti-sortilin (neurotensin 
receptor 3) mouse antibody is from BD biosciences (San Diego, CA). Rabbit 
polyclonal anti-cellugyrin was made by Biosource International (Camarillo, CA). 
Polyclonal AS160  was a kind gift from Dr. Paul Pilch made by Dr. Michael 
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Czech’s lab. Mouse monoclonal FLAG antibody was purchased from Sigma (St. 
Louis, MO). 
C. METHODS 
1. Cell Culture 
3T3-L1 pre-adipocytes were grown in Dulbecco’s modified Eagle’s 
Medium (DMEM) with 10% donor bovine serum and 1% penicillin-streptomycin 
glutamine (PSG). To differentiate, the cells were grown to confluence and 
switched to differentiation media (10% Fetal Bovine Serum (FBS), 1% penicillin-
streptomycin glutamine, 0.5mM 3-isobutyl-1-methlxanthine, 1 uM 
dexamethasone and 167nM insulin, 2uM troglitazone) 2 days later. This media 
was replaced with adipocyte maintenance media (+troglitazone) after 48h 
(DMEM, 10% FBS, 1% PSG, 2uM) and then changed every 2 days.  
Differentiated cells were used on day 5-8 unless otherwise stated. 
2. cDNA 
As described in previous publications from the lab, Jun Shi made the 
retroviral cDNA constructs mLNCX2-sortilin-mycHis and pBabe-myc7-GLUT4 
(Shi and Kandror, 2005). FLAG-tagged AS160 and 6P mutant cDNA were a kind 
gift from Gus Lienhard. pCMV-FLAG was a kind gift from the Layne lab. 
3. Stable Cell Lines 
Description of cell lines used in these studies 
• S+ cells: 3T3-L1 fibroblasts expressing exogenous sortilin  
• High G cells: 3T3-L1 fibroblasts expressing high levels of GLUT4 
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• Low G cells: 3T3-L1 fibroblasts expressing low levels of GLUT4 
• GS cells: 3T3-L1 fibroblasts expressing sortilin and high levels of GLUT4 
Stably transfected 3T3-L1 cell lines were made by Jun Shi using retrovirus 
infection. mLNCX2-sortilin-myc/His (S cells) are selected with 250ug/mL G418, 
3T3-L1 cells stably transfected with pBabe-myc7-Glut4 (G cells) are selected 
with 3.75ug/mL puromycin and 3T3-L1 cells stably transfected with both pBabe-
myc7-Glut4 and mLNCX2-sortilin-myc/His were selected with both 250ug/mL 
G418 and 3.75ug/uL puromycin. 
4. Gel Electrophoresis and Immunoblotting 
10% polyacrylamide SDS-PAGE gels were used for Western Blotting 
according to Laemmli protocol unless otherwise stated. Samples were prepared 
to a final concentration of 1X Laemmli buffer with 10% β-mercaptoethanol, run on 
the gel, and transferred to Polyvinylidene fluoride (PVDF) membranes (Millipore, 
Billerica, MA) in 30 mM Tris and 192 mM glycine overnight at 4°C. The 
membrane was blocked in 10% Bovine Serum Albumin in phospho-buffered 
saline with 0.5% Tween 20) for 1 hour at room temperature. Primary antibody 
incubation took place at 4°C shaking overnight and secondary antibodies for an 
hour at room temperature. An enhanced chemiluminescence kit was used to 
develop blots and they were exposed on a Kodak Image Station 440CF or a 
BioRad imager. 
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5. Plasma Membrane Lawns 
Plasma membrane lawns were made as previously described (Robinson et al., 
1992). 3T3-L1 adipocytes expressing sortilin myc/His were starved for 2 hours in 
plain, serum-free DMEM after 2 washes with plain DMEM. The cells were 
stimulated or not with 100nM insulin for 15 minutes at 37°C. The cells were 
washed and briefly (3 minutes) incubated in a hypotonic 1/3 X KHMgE buffer 
(70mM KCl, 30mM HEPES, 5mM MgCl2, 3mM EGTA pH 7.5). The cells were 
sonicated with a handheld sonicator for a brief (1 second) pulse before fixation 
and subsequent staining with the plasma membrane marker wheat germ 
agglutinin and the myc antibody. 
6. Subcellular fractionation of 3T3-L1 cells 
 3T3-L1 adipocytes or pre-adipocytes were washed twice with warm 
serum-free DMEM and then serum starved in this plain media for 2 hours. The 
cells were stimulated or not with 100nM insulin for 15 minutes at 37°C. The cells 
were washed once with PBS and once with HES (250mM sucrose, 20mM 
HEPES, 1mM EDTA, pH 7.4 with inhibitors) and then homogenized in HES buffer 
(1mL total per condition). After 11 strokes with a ball-bearing homogenizer with 
12 µm clearance (Isobiotec, Heidelberg, Germany) the homogenate was spun at 
a low speed for 10 minutes to remove debris and the resulting supernatant was 
spun at 26,000g Beckman 42.2 Ti rotor for 35 minutes (Simpson et al., 1983).  
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7. Sucrose Gradient Centrifugation 
After homogenization and the first spin, the supernatant was collected and 
analyzed for protein content, equal amounts of protein (~1mg) from the combined 
supernatants were loaded on a 4.6 mL 10-30% sucrose cushion and 
ultracentrifuged at 250,000g (48,000rpm) in a Sorvall AH-650 rotor for 1h. A 
perfusion pump was used to collect 22-26 fractions from bottom to top drop-wise 
and the resultant fractions analyzed using Western blotting (Shi and Kandror, 
2005). 
8. Cell surface biotinylation 
S+ pre-adipocytes were starved for 1 hour in KRH buffer (121mM NaCl, 
12mM HEPES, 4.9mM KCl, 1.2mM MgSO4, 0.33mM CaCl2) following two 
washes with the buffer. EZ-Link NHS-SS biotin was diluted in KRH and added to 
a final concentration of 0.8mM.The insulin was added to a final concentration of 
100nM for 2 minutes and then the biotin was added and incubated at 37°C for 30 
minutes. Tris pH 8.0 was added to a final concentration of 50mM to quench 
excess biotin. The plates were washed twice with PBS, once in HES buffer, and 
then harvested in HES buffer (500uL/ 15cm dish). The cells were then 
homogenized in HES buffer with 11 strokes with a ball-bearing homogenizer with 
12 µm clearance (Isobiotec, Heidelberg, Germany). After a 10-minute cold spin at 
3,000g, the resulting supernatant was spun at 150,000g for 2 hours. The 
resulting pellet was resuspended in a small amount of lysis buffer (150uL) and 
assayed for protein concentration. 100-150ug of protein was loaded on 
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streptavidin agarose beads and incubated overnight rotating at 4°C. The 
supernatant was collected to be analyzed separately as the unbound fraction and 
the beads were subsequently washed 3 times with lysis buffer and then 1 time 
with PBS. Laemmli buffer with 50mM DTT was added to a final concentration of 
1X and the samples were eluted from the beads by shaking at 170rpm at 37°C 
for 90 minutes. The eluate, whole cell lysate and unbound fraction were analyzed 
by Western blotting. 
9. 3H-2-Deoxyglucose uptake 
Adipocytes in 6-well plates were washed twice with serum-free DMEM and 
then serum starved in 2mL of plain DMEM for 2 hours with or without the 
presence of 500uM palmitate. The palmitate was first dissolved in EtOH to a 
stock solution of 10mM by heating to 65°C. The cells were washed twice with 
Krebs-Ringer-HEPES (KRH) buffer warmed to 37°C (121mM NaCl, 4.9mM KCl, 
1.2mM MgSO4, 0.33mM CaCl2, 12mM HEPES, pH 7.4) and then treated with 
100nM insulin or carrier (5mM HCL) at 37°C for 15 min. 3H-2-Deoxyglucose (0.1 
mM, 0.625 pCi/ml) was added for 4 minutes at 37°C. The reaction was quenched 
by removing the radioactive cocktail and washing 3 times with cold KRH buffer 
containing 25mM D-glucose. Each well was lysed with 400µL of 0.1% SDS in 
KRH and 300µL of each was used for liquid scintillation counting. Measurements 
were made in duplicates and corrected for specific activity and nonspecific 
diffusion (determined by using 5µM cytochalasin B). A BCA protein assay kit was 
used to determine the protein concentration and normalize the counts. 
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10. Transient transfection of pre-adipocytes 
GS pre-adipocytes were grown in 150mm dishes. Cells were washed with 
PBS, trypsinized, and resuspended in 40mL of complete media. Cells were then 
spun down at room temperature for 4 minutes at 800 rpm and resuspended in 
40mL of DPBS. Cells were washed this way 2 times before resuspending in 
500uL electroporation buffer. After counting cells, 60ug of AS160 cDNA+ 20ug 
GFP cDNA was added to the cuvet (or 80ug GFP as control for 
immunofluorescence) and then cells were added. Electroporation buffer was 
added up to 500uL total volume and cells were electroporated using a Gene 
Pulser MXcell Electroporation System at 950 µF, 0.16 kV. 1 mL complete media 
was added to the cells, the dead cells were removed from the surface, and after 
10 minutes cells were either plated into 10cm dishes for subsequent Western 
blotting, or plated on collagen coated coverslips in a 24-well plate for 
immunofluorescent analysis. The media was changed the next day and cells 
were assayed after 2 days. 
Alternatively, GS pre-adipocytes were grown on collagen-coated 
coverslips in a 24-well plate for immunofluorescence or grown on a 60mm dish 
for Western blotting and transfected according to manufacturers instructions 
using Lipofectamine 2000. 0.2ug mutant 6P cDNA (+0.1ug GFP) was used for 
immunofluorescent experiments (or 0.2ug EV+ 0.1ug GFP as a control) and 2ug 
of mutant 6P cDNA (or 2ug EV) was used for Western blotting. 
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11. Immunofluorescence 
Cells were grown on (pre-adipocytes) or replated (adipocytes on Day 5) 
onto collagen-coated coverslips. Cells were treated or not with 100nM insulin, 
fixed in 4% paraformaldehyde (pH 7.4) and permeabilized or not with 0.2% 
Triton. Before antibodies were added, cells were blocked in 5% serum and 5% 
bovine serum albumin. The cells were incubated with primary antibodies 
overnight at 4°C and then secondaries for an hour at room temperature. 
Coverslips were mounted using Invitrogens SlowFade-Light Antifade Kit. Images 
were taken using an Axio Observer Z1 fluorescence microscope and Axiovision 
4.8.1 program (Carl Zeiss Inc., Thornwood, NY). Images were matched for 
exposure and cells were analyzed on an individual basis, counting positive cells 
or using NIH ImageJ software to quantify fluorescent intensity normalized to cell 
area and background was subtracted from each image. 
12. Super-Resolution Microscopy  
PALM (Photo-activation localization microscopy) images were collected at 
Harvard’s imaging facility. This technique utilizes photoswitchable fluorophores 
that are sequentially activated and deactivated in order to precisely determine 
their location at high resolution. S+ and High G pre-adipocytes were plated on 
collagen-coated chamber slides and fixed/permeabilized/blocked/stained with 
myc antibody as described in the Immunofluorescence section above. Cells were 
stored in PBS and just before imaging they were switched into an imaging buffer 
(50mM Tris pH 8.0, 10mM NaCl, 10% glucose, 20mM cysteamine, 0.5mg/mL 
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glucose-oxidase Type VII and 40ug/mL: a 10X stock buffer containing glucose 
oxidase, catalase, Tris, and NaCl was used). Images were taken at 100X. 
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III. RESULTS 
 
A. CHAPTER 1 
 
1. Ectopically expressed sortilin shows insulin responsiveness in 3T3-L1 
pre-adipocytes and adipocytes 
 As mentioned previously, 3T3-L1 pre-adipocytes do not express GLUT4 or 
sortilin. Upon the induction of sortilin on day 3 of differentiation, the insulin 
responsive compartment (IRVs) is formed and then subsequently expressed 
GLUT4 is incorporated into this compartment on day 4 (El-Jack et al., 1999; Shi 
and Kandror, 2005). The insulin responsiveness of GLUT4 is not acquired by wild 
type 3T3-L1 cells until day 4 of differentiation when it is incorporated into IRVs. 
Exogenously expressed GLUT4 does not show insulin responsiveness on its own 
and is also very unstable in the pre-adipocyte. Our lab has previously shown that 
sortilin is necessary for the formation of the IRV but to further examine its role in 
the formation we looked at the translocation properties of sortilin in both pre-
adipocytes and fully differentiated cells (Shi and Kandror, 2005). 
     a. Sortilin translocates in response to insulin in 3T3-L1 adipocytes 
expressing myc/His sortilin 
To study the translocation of sortilin in response to insulin, we used 3T3-
L1 adipocytes ectopically expressing sortilin that has been tagged with myc and 
His on its cytoplasmic C-terminus (S+) (Figure 8). In order to expose this tag and 
show translocation immunofluorescently, a plasma membrane sheet assay was 
used, as described in the methods section (Figure 9A). This technique is  
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Figure 8. Sortilin reporter protein (contributed by Jun Shi) 
 Sortilin is tagged with myc and His at its C-terminal, cytoplasmic domain. 
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commonly used to study membrane proteins and was first described by 
Robinson et al who used it to study GLUT4 translocation in 3T3-L1 adipocytes 
(Robinson et al., 1992). This reporter protein behaves like the endogenous 
protein and localizes to the vesicular compartment. As shown in Figure 9B, 
sortilin translocates to the plasma membrane and inserts itself into the plasma 
membrane in response to insulin stimulation. This technique was unsuccessful in 
pre-adipocytes, likely due to their cellular morphology and resistance to osmotic 
shock. 
     b. Ectopically expressed sortilin shows insulin responsiveness in 3T3-
L1 pre-adipocytes 
Due to the fact that 3T3-L1 adipocytes are known to have fully functional 
IRVs that contain sortilin, sortilin’s translocation in the IRV in response to insulin 
is not surprising. We did, however, examine the localization and translocation of 
ectopically expressed mLCNX2-sortilin-myc/His in a pre-adipocyte where other 
components of the mature IRV are not present. We’ve shown that in a basal 
state, exogenous sortilin localizes mainly to the perinuclear compartment (Figure 
10A). It is important to note that the expression level of the exogenous sortilin in 
pre-adipocytes is equivalent to that of the endogenous protein in adipocytes. It 
has also been previously shown that when sortilin is expressed alone in pre-
adipocytes it still localizes to the vesicular fraction. We used a cell surface 
biotinylation assay in which a membrane impermeable biotin reagent was added 
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Figure 9. Ectopically expressed sortilin-myc/His localizes to IRV 
compartment and is translocated to the plasma membrane of 3T3-L1 
adipocytes in response to insulin 
A) Schematic of plasma membrane lawn preparation 
B) 3T3-L1 adipocytes in a 24 well plate were serum starved, stimulated or not 
with 100nM insulin, swollen in KHMgE, a hypotonic buffer and briefly sonicated 
with a handheld sonicator, leaving only the plasma membrane attached to the 
plate. The plasma membrane sheets were co-stained with Wheat Germ 
agglutinin (red), a plasma membrane marker, and myc monoclonal antibody 
(green). 
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to S+ pre-adipocytes in the presence or absence of insulin and the reaction was 
allowed to occur for 30 minutes, then quenched. By pulling down biotinylated 
proteins, we showed that in response to insulin stimulation, sortilin translocates 
to the plasma membrane in pre-adipocytes as well (Figure 10 B-C). Unlike pure 
cargo of the IRV like GLUT4, sortlin can translocate in response to insulin 
independently, making it a viable candidate for conferring insulin responsiveness 
to the vesicle. 
     c. Sortilin confers insulin responsiveness to GLUT4 in 3T3-L1 pre-
adipocytes 
To expand upon the finding that sortilin is insulin responsive on its own, we 
examined whether sortilin is conferring insulin responsiveness to GLUT4. We 
used 3T3-L1 pre-adipocytes stably transfected with different levels of GLUT4, 
tagged in its first luminal loop with 7 myc epitopes (referred to from now on as 
myc7-GLUT4) with or without sortilin-myc/His co-expression in a differentially 
selected vector. Using immunofluorescent analysis of non-permeabilized cells we 
examined the translocation of myc7-GLUT4 in response to insulin. Pre-
adipocytes expressing sortilin and GLUT4 (GS) (Figure 11C) show more insulin 
responsiveness (∼2 fold) than those cells expressing either high (Figure 11B) or 
low (Figure 11A) levels of GLUT4 alone (Quantification shown in Figure 11D). 
Due to sortilin’s ability to stabilize ectopically expressed GLUT4 in pre-
adipocytes, GS cells do express slightly more GLUT4 than their High G 
counterpart, but not enough to account for the large difference in insulin- 
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Figure 10. Ectopically expressed sortilin-myc/His is localized to small 
vesicles and translocates to the plasma membrane in 3T3-L1 pre-
adipocytes 
A. Undifferentiated S+ pre-adipocytes as analyzed by PALM/dSTORM imaging 
analysis at Harvard University imaging facility. Cells were stained using cy3 
secondary and sortilin molecules are represented here. 
B. Undifferentiated S+ pre-adipocytes were serum starved, stimulated or not with 
100nM insulin and biotinylated with 0.5mg/mL of cleavable sulfo-NHS-SS biotin 
reagent in KRH buffer. Cells were homogenized and after isolating the 
membrane fractions, the biotinylated proteins were pulled down using 
streptavidin-agarose beads and the resulting eluate was analyzed by Western 
blotting with anti-myc. The total cell lysate and unbound material was also 
analyzed. 
C. Quantitative analysis of basal vs insulin stimulated biotinylation in five 
individual experiments. Error bars are standard error. P =0.08. 
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stimulated translocation.  
Despite their ability to traffic GLUT4 to the plasma membrane in response to 
insulin, GS pre-adipocytes do not show insulin responsiveness equivalent to that 
of a fully differentiated cell. The pre-adipocytes contain both GLUT4 and sortilin 
but as shown in Figure 11C, GS pre-adipocytes have GLUT4 at the plasma 
membrane, even in the absence of insulin. This is a stark contrast to Figure 11G 
where GS adipocytes are able to fully retain GLUT4 intracellularly in the absence 
of insulin. Fully differentiated adipocytes are able to robustly respond to insulin by 
translocating GLUT4 8 fold over basal (Figure 11G-H). This is 4 fold higher than 
GLUT4 translocation in a GS pre-adipocyte (Figure 11C). 
Figure 11 E, F and G show basal and insulin stimulated GLUT4 
translocation of fully differentiated Low G, High G and GS adipocytes 
respectively. Demonstrated here is their dramatically increased ability to 
translocate GLUT4 in response to insulin (Figure 11H). No GLUT4 is present at 
the plasma membrane in the absence of insulin in adipocytes, showing that 
adipocytes possess a mechanism to sequester GLUT4 intracellularly. 
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Figure 11. Translocation of myc7-GLUT4 in pre-adipocytes and adipocytes 
3T3-L1 pre-adipocytes expressing low levels of GLUT4 (Low G) (A), high 
levels of GLUT4 (High G) (B) or high levels of GLUT4 with sortilin (GS) (C) were 
grown on or replated onto collagen-coated coverslips. The cells treated (+) or not 
treated (-) with 100nM insulin after 2 hours of serum starvation, fixed, and then 
analyzed by immunofluorescent staining with the myc antibody to detect 
translocated GLUT4. The images were taken using an Axio Observer Z1 
fluorescence microscope and analyzed using ImageJ software. Quantification 
was performed counting no less than 70 pre-adipocytes and no less than 23 
insulin stimulated adipocytes.  
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2. The ability of cells to sequester IRVs after differentiation depends on the 
expression of AS160 
 As shown in Figure 11, though GS pre-adipocytes are able to form the 
IRVs, GLUT4 is still present at the plasma membrane in the absence of insulin. 
The inability to seqester GLUT4 inside the cell points to a missing protein in the 
pre-adipocyte. The putative tethering proteins have been examined by other labs 
and the TUG protein that interacts with GLUT4 has been discovered as a viable 
candidate for tethering the IRV. Another mechanism for tethering IRVs in the 
basal state could involve the interaction of IRAP with the proteins Rab GTPase 
activating protein AS160 and one of its Rab targets, Rab10.  
      a. AS160 is expressed upon differentiation from pre-adipocytes to 
adipocytes 
 To further characterize these potential mechanisms for tethering, we 
examined the expression of the proteins in our cells. In Figure 12 we have shown 
that TUG is present in 3T3-L1 pre-adipocytes and actually decreases upon 
differentiation to mature adipocytes. TUG, though it has been shown to have 
involvement in tethering GLUT4 (Bogan et al., 2003), and shown to be important 
in the translocation of GLUT4 (Yu et al., 2007) is not the main candidate for 
sequestering IRVs intracellularly in adipocytes. It may in fact be responsible for 
the small amount of retention that does exist in GS preadipocytes. Rab10 and 
AS160 may work together in order to maintain GLUT4 inside an unstimulated cell 
but as shown in Figure 12, Rab10 also decreases upon differentiation. It has 	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Figure 12. Protein expression in GS pre-adipocytes and adipocytes 
Total lysates of GS pre-adipocytes (40ug) or fully differentiated adipocytes 
(40, 20, 10 and 5ug) were examined by Western Blotting with the indicated 
antibodies. Cell differentiation shows an increase in AS160 and IRAP 
concurrently with a decrease in TUG and Rab10. 	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been previously shown to be required for the insulin-stimulated translocation of 
GLUT4, but also does not seem to be the sole requirement for tethering GLUT4 
(Sano et al., 2007).  
Several studies using a loss-of-function approach show that AS160 is 
required for basal retention (Eguez et al., 2005; Larance et al., 2005; Brewer et 
al., 2011). Upon examination of AS160, we find that it is expressed at a low level 
in 3T3-L1 pre-adipocytes, about ¼ of the amount present in adipocytes (Figure 
12), and is strongly induced upon differentiation (Figure 13 A-B). This induction 
on Day 3 is concurrent with sortilin and the formation of the insulin responsive 
compartment and makes AS160 a viable candidate for conferring intracellular 
GLUT4 retention to adipocytes. Our data agrees with previous data showing the 
importance of AS160 in GLUT4 translocation in adpocytes (Eguez et al., 2005). 
Figure 13 also demonstrates the decreasing levels of Rab10 and TUG across 
differentiation which shows their less significant role in GLUT4 sequestration in 
adipocytes.  
AS160 has been shown to interact with IRAP and LRP1 and not with 
GLUT4 (Larance et al., 2005; Peck et al., 2006; Jedrychowski et al., 2010), we 
examined whether AS160 might interact with sortilin as well. Using fully 
differentiated S+ adipocytes, anti-myc was used to pull down sortilin and lysates 
were then probed for the presence of AS160 (Figure 14). No interaction was 
observed between endogenous AS160 and sortilin myc/His.	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Figure 13. AS160 is induced upon differentiation of 3T3-L1 cells 
 WT (A) or GS (B) 3T3-L1 cells were differentiated in 60mm dishes and 
harvested on different days of differentiation. 50ug of the total lysates were 
examined by Western Blotting with the indicated antibodies AS160, Sortilin, 
LRP1 (Maneet Singh), TUG, GAPDH, Rab10. 	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Figure 14. Endogenous AS160 does not directly interact with sortilin in 
adipocytes 
 Day 6 3T3-L1 S+ adipocytes were harvested and their protein 
concentration determined by BCA. 700ug of protein was loaded on sheep anti-
mouse Dyna beads with 2uL of myc antibody or IgG antibody. After an overnight 
incubation, proteins were eluted in Laemmli buffer with 10% β-mercaptoethanol 
and the resulting eluate run on a Western blot and probed for the presence of 
AS160. 
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     b. Expression of AS160 is sufficient to sequester GLUT4 in basal pre-
adipocytes 
 To determine if AS160 is responsible for the intracellular retention 
mechanism that is obtained upon differentiation, we overexpressed FLAG-tagged 
AS160 cDNA in GS pre-adipocytes by electroporation. GS pre-adipocytes are 
known to be able to form the insulin responsive compartment, but unable to 
successfully retain GLUT4 in the absence of insulin (Figure 11 A-D). 
Electroporation has long been used as a means to introduce DNA into cells and 
was efficiently utilized in this situation as evidenced by the presence of GFP 
which was used as a marker of effective transfection. By electroporating GS pre-
adipocytes with AS160 and GFP or GFP alone, we show that the cells 
expressing AS160 are able to retain GLUT4 in the absence of insulin (Figure 
15A). Most cells that were successfully transfected with AS160 cDNA lack any 
plasma membrane staining (red, myc staining) whereas surrounding, 
untransfected cells still show basal GLUT4 at the plasma membrane (Figure 15A 
and C). GFP electroporated separately into cells as a negative control shows that 
over 80% of the cells still have plasma membrane staining, indicating that the act 
of electroporation itself is not causing a decrease plasma membrane staining 
(Figure 15 B-C). 
The mutant 6P form of AS160  was also introduced into the cells. This 
mutant has its 6 putative Akt phosphorylation sites mutated from serines or 
threonines to alanines, making it unable to participate in insulin response. As 
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shown in Figure 15D, the mutant AS160 also increases basal GLUT4 retention 
while the expression of empty pCMV vector alone is unable to rid the cells of 
GLUT4 at the plasma membrane (Figure 15 E-F). 
In order to examine the physiological relevance of this exogenous, 
transiently expressed protein, the AS160-electroporated GS pre-adipocytes were 
treated with or without insulin. Here we show that GLUT4 was able to translocate 
to the plasma membrane in cells expressing AS160 (Figure 16A), but not mutant 
6P (Figure 16D). The wild-type exogenous protein in pre-adipocytes acts the 
same way as the endogenous protein is suspected to behave in adipocytes. The 
presence of AS160 allows the pre-adipocytes to maintain GLUT4 intracellularly in 
the absence of insulin and translocate GLUT4 to the plasma membrane in 
response to insulin stimulation. 
We also examined the behavior and functionality of wild-type and 6P 
mutant biochemically. GS pre-adipocytes were electroporated with WT or mutant 
AS160 and stimulated or not with insulin as before. The samples were then 
harvested and analyzed with a phospho-AS160 antibody by Western blotting. 
The exogenous wild type AS160 is phosphorylated in response to insulin while 
the mutant protein is not, showing again that our exogenous FLAG-tagged 
AS160 behaves like wild type AS160 (Figure 17). It is possible that these effects 
of insulin are not being mediated through the insulin receptor (IR) itself, as it has 
a very low expression level in pre-adipocytes but rather through a hybrid receptor  
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Figure 15. Exogenously expressed AS160 causes basal retention of GLUT4 
in pre-adipocytes 
AS160 cDNA or 6P mutant AS160 cDNA was expressed in GS pre-adipocytes. 
GFP was cotransfected and used as a marker for transfection. 48 hours later the 
cells were analyzed for the presence of myc7-GLUT4 at the plasma membrane 
by detection with myc antibody and a red cy3 secondary. Pictures were taken on 
an Axio Observer Z1 fluorescence microscope. 
A) Cells were transfected by electroporation with AS160+GFP (60ug+20ug GFP) 
B) Cells were transfected by electroporation with GFP alone (80ug total).  
C) Quantification of cells with GLUT4 at the plasma membrane, standard 
deviation represented in error bars. 
D) Cells were transfected by Lipofectamine 2000 with 6P mutant AS160 
(0.2ug/well+0.1ug/well GFP)  
E) Cells were transfected by Lipofectamine 2000 with EV+GFP 
(0.2ug/well+0.1ug/well GFP) 
F) Quantification of cells with GLUT4 at the plasma membrane, standard 
deviation represented in error bars. 
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involving the IR and insulin-like growth factor receptor I (IGF-IR) (Back and 
Arnqvist, 2009). 
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Figure 16. Exogenous expression of AS160 is sufficient to retain GLUT4 
and increase insulin responsiveness in pre-adipocytes. 
AS160 cDNA or 6P mutant AS160 cDNA were expressed in GS pre-adipocytes. 
GFP was cotransfected and used as a marker for transfection. 48 hours later the 
cells were serum starved and stimulated or not with 100nM insulin, fixed 
analyzed for the presence of myc7-GLUT4 at the plasma membrane by detection 
with myc antibody and a red cy3 secondary. Pictures were taken on an Axio 
Observer Z1 fluorescence microscope. 
A) Cells were transfected by electroporation with AS160+GFP (60ug+20ug GFP)  
B) Cells were transfected by electroporation with GFP alone (80ug total).  
C) Quantification of 3 experiments ** -p<0.01. 
D) Cells were transfected by Lipofectamine 2000 with 6P mutant AS160 
(0.2ug/well+0.1ug/well GFP)  
E) Cells were transfected by Lipofectamine 2000 with EV+ GFP 
(0.2ug/well+0.1ug/well GFP)  
F) Quantification of 3 experiments *- p<0.05, ** -p<0.01 
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Figure 17. Exogenous AS160 is phosphorylated in response to insulin 
AS160 (2ug/60mm dish of WT, 6P or pCMV-FLAG EV) was expressed in 
GS pre-adipocytes using Lipofectamine 2000. 48 hours later the cells were 
serum starved and stimulated or not with 100nM insulin, harvested, and 60ug of 
protein was examined by Western Blotting with the indicated antibodies. 
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c.  Exogenous AS160 does not directly interact with sortilin or 
GLUT4 in pre-adipocytes or adipocytes  
 Continuing to examine GS pre-adipocytes transfected with AS160, 
immunofluorescent analysis was conducted to visualize any co-localization of 
FLAG-tagged AS160 with myc-tagged proteins (sortilin or GLUT4) . Minimal co-
localization was observed between these proteins (Figure 18). Despite the fact 
that GS pre-adipocytes do have IRVs, a better measure of AS160 localization 
would need to be examined in adipocytes. In order to examine localization in 
adipocytes we electroporated High G adipocytes with AS160 (Figure 19). Similar 
to the preadipocytes, AS160 does not dramatically colocalize with GLUT4.  	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Figure 18. Limited colocalization between exogenous AS160 and myc-
tagged proteins in GS Pre-adipocytes 
AS160 (60ug+20ug GFP) was expressed in GS pre-adipocytes using 
electroporation. 48 hours later the cells were permeabilized, fixed, and analyzed 
for co-localization of FLAG-tagged AS160. Pictures were taken on an Axio 
Observer Z1 fluorescence microscope. The blown up insert is a close-up of the 
perinuclear region of the image. 	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Figure 19. Limited colocalization between exogenous AS160 and GLUT4 in 
High G adipocytes 
AS160 (60ug+20ug GFP) was expressed in High G adipocytes using 
electroporation. 48 hours later the cells were permeabilized, fixed, and analyzed 
for co-localization of FLAG-tagged AS160. Pictures were taken on an Axio 
Observer Z1 fluorescence microscope. The blown up insert is a close-up of the 
perinuclear region of the image. 	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B. CHAPTER 2  
1. Free fatty acids form stress granules and contribute to the development 
of insulin resistance via ACSL1-dependent mechanisms  
Decreased response to insulin is a hallmark of insulin resistance that 
develops secondary to obesity. By using palmitic acid as a representative 
saturated fatty acid, we studied the effects of elevated levels of free fatty acids on 
3T3-L1 adipocytes. Palmitate concentrations in the blood range from 100-150uM 
but the concentration of saturated fatty acids as a whole can be as high as 1mM 
(Reaven et al., 1988). For this reason and because it has been shown to have an 
effect at concentrations of 300uM-500uM (Karki et al., 2011), we used palmitate 
at a concentration of 500uM in our experiments. To test the effects of palmitate 
on insulin signaling, we harvested samples of wild-type adipocytes after 
incubation with 500uM palmitate for different periods of time and analyzed the 
samples for components of the insulin-signaling pathway. As shown in Figure 20, 
pretreatment with palmitate attenuates insulin signaling in 3T3-L1 adipocytes. To 
further analyze the physiological translation of this decrease in signaling, 
radioactive glucose uptake was used as a measure of adipocyte function. 
Pretreating the cells with palmitic acid decreased insulin-stimulated glucose 
uptake in a time-dependent fashion, showing that adipocytes are less effectively 
clearing glucose in the presence of palmitic acid (Figure 21). These results are 
consistent with previous studies showing that free fatty acids decrease the ability 
of insulin to induce significant signaling cascades (Nguyen et al., 2005) and also  
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Figure 20.  Pre-incubation with palmitic acid attenuates insulin signaling in 
3T3-L1 adipocytes 
 Day 6 3T3-L1 adipocytes were washed with serum free media and 
incubated with 500uM palmitate dissolved in EtOH or EtOH alone for the 
indicated periods of time. For the last 15 minutes, 100nM insulin was added to 
stimulate cells. Cells were harvested and 40ug of protein was examined by 
Western Blotting with the indicated antibodies. 
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they inhibit insulin-stimulated glucose uptake and metabolism (Boden et al., 
1991; Boden and Chen, 1995).  
It is possible that the effect of ACSL1 on insulin sensitivity in response to 
fatty acids is modulated through its direct interaction with sortilin (Huang, 2010). 
Using a 3T3-L1 cell line where ACSL1 has been knocked down with shRNA, a 
lab member overexpressed our sortilin-myc/His reporter protein. We examined 
the distribution of sortilin in these cells as compared to our cells that contain 
ACSL-1 and found that sortilin completely loses its perinuclear localization in the 
knockdown cell line (Figure 22). Without proper localization of sortilin, which 
we’ve determined is conferring insulin sensitivity, the cells would not be able to 
respond to insulin as efficiently as a wild-type cell. 
As previously mentioned, it has been shown that incubation with palmitic 
acid results in decreased adiponectin secretion leading to less insulin sensitivity, 
an effect mediated by ER stress and lysosomal degradation (Zhou et al., 2010; 
Karki et al., 2011). Because palmitate also decreased levels of adiponectin 
mRNA we examined whether or not 3T3-L1 adipocytes could be forming stress 
granules as sites of stalled mRNA translation. Using mouse embryonic 
fibroblasts (a cell line known to develop stress granules) and sodium arsenite (a 
compound known to induce the formation of stress granules through oxidative 
stress) we showed the development of stress granules. Using the same 
conditions on 3T3-L1 adipocytes on Day 6 we saw the formation of the same 
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Figure 21. Pre-incubation with palmitic acid decreases insulin-stimulated 
glucose uptake in a time-dependent manner 
Adipocytes were washed twice with serum-free DMEM and then incubated 
with 500uM palmitate in serum free media for the indicated time periods. The 
cells were washed twice with KRH buffer and then treated with 100nM insulin or 
carrier (5mM HCL) at 37°C for 15 min. 3H-2-Deoxyglucose was added for 4 
minutes at 37°C. The reaction was quenched by removing the radioactive 
cocktail and washing 3 times with cold KRH buffer containing 25mM D-glucose. 
Each well was lysed with 400µL of 0.1% SDS in KRH and 300µL of each was 
used for liquid scintillation counting. Counts were normalized to protein 
concentration as determined by BCA. 
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structures (Figure 23). At the same time, a final concentration of 500uM  
palmitate was added for 1.5h to 3T3-L1 adipocytes and showed that palmitate 
also induces the formation of stress granules. It is possible that this is the 
mechanism for decreasing mRNA transcripts of adiponectin while the ER 
decreases translation and the cell targets more adiponectin for lysosomal 
degradation. These mechanisms could all be working together to decrease levels 
of this insulin-sensitizing adipokine and induce insulin resistance. 
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Figure 22. Loss of ACSL-1 ablates the perinuclear localization of sortilin in 
3T3-L1 pre-adipocytes 
Pre-adipocytes expressing sortlin-myc/His with or without ACSL1 (S+ vs 
S+ ACSL KD respectively) were permeabilized and stained with myc antibody to 
label sortilin. (Figure data was obtained with assistance from Khsitij Khatri. 
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Figure 23. Incubation of palmitic acid induces formation of stress granules 
in 3T3-L1 adipocytes 
Day 6 3T3-L1 adipocytes or mouse embryonic fibroblasts were washed 
with serum free media and incubated with 500uM palmitate dissolved in EtOH, 
0.5mM arsenite or EtOH alone for 1.5 hours and then fixed and stained for the 
presence of eIF3, a stress granule component. 
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IV. DISCUSSION 
A. CHAPTER 1 
1. Sortilin and AS160, the acquisition of insulin responsiveness 
The characterization of proteins of the insulin responsive vesicle has been 
a subject of research by many different groups for many years. Discovering 
which protein or proteins is responsible for conferring insulin responsiveness to 
the GLUT4 transporter has major implications in the treatment of insulin 
resistance and potential prevention of type 2 diabetes. Sortilin, as a member of a 
sorting family of protein receptors, has varying functions in different cells types, 
but our lab and others have shown that it is necessary for the formation of IRVs 
in differentiated 3T3-L1 adipocytes and that in undifferentiated cells it is sufficient 
for the formation of these vesicles (Shi and Kandror, 2005; Ariga et al., 2008). In 
addition to vesicle formation, sortilin may be functioning to retrieve GLUT4 from 
the early endosome to the specialized IRV compartment where it remains until 
insulin stimulation occurs (Figure 5) (Hatakeyama and Kanzaki, 2011). It is 
known that sortilin is present in the transport vesicles going from the endosome 
to TGN and that it cycles between these two compartments (Nielsen et al., 2001; 
Mari et al., 2008).  Here we show that sortilin is responsible for the insulin 
sensitivity demonstrated by the mature adipocytes. 
To demonstrate sortilin’s role in insulin stimulated glucose clearance it 
was important to show that sortilin alone is capable of translocation in response 
to insulin stimulation. Unlike IRAP and GLUT4, when sortilin is expressed alone 
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in pre-adipocytes, it does target to the small vesicular fraction (Figure 9A). We 
used a 3T3-L1 stably transfected cell line that expresses myc/His tagged sortilin 
(S+ cells) in order to study the translocation properties of sortilin alone (Figure 8).  
A plasma membrane sheet assay was used to expose the cytoplasmic myc tag 
of sortilin that had translocated to the plasma membrane in response to insulin. 
With this technique we showed that sortilin is translocating to the plasma 
membrane along with GLUT4 in a mature adipocyte (Figure 9B). Despite the fact 
that we can observe this translocation in adipocytes it was important to see that 
sortilin could translocate in response to insulin in a pre-adipocyte as well. In a 
pre-adipocyte other proteins associated with differentiation are not expressed so 
any observed translocation is due to properties of sortilin alone. Using a cell-
surface biotinylation assay we showed that sortilin translocates to the plasma 
membrane in response to insulin in a sortilin expressing (S+) pre-adipocyte, 
making its potential role in insulin responsiveness even more prevalent (Figure 
10B). 
To address the question of whether the presence of sortilin is enough to 
confer insulin responsiveness to GLUT4 in the pre-adipocyte, we used three 
different stably transfected cell lines. Low G, High G and GS cells are pre-
adipocytes expressing low levels of GLUT4, high levels of GLUT4 and high levels 
of GLUT4 plus sortilin respectively. Merely increasing the levels of GLUT4 by 4-
fold in the pre-adipocyte from Low to High G cells did not increase the 
responsiveness of the cells to insulin stimulation (Figure 11 A, B and D). 
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However, adding sortilin to the higher expressing cells dramatically increased the 
ability of GLUT4 to translocate to the plasma membrane in response to insulin 
(Figure 11 C and D).  Sortilin does stabilize the expression of exogenously 
expressed GLUT4 but this slight increase in GLUT4 levels does not account for 
the dramatic increase in insulin responsiveness (Shi and Kandror, 2005; Liu et 
al., 2007). Interestingly, despite the increase in insulin responsiveness (from 1.2 
fold in High G cells to 2 fold in GS cells), the GS pre-adipocytes still do not 
respond to insulin as robustly as a fully mature adipocyte. The cells that are not 
stimulated with insulin still have a large amount of GLUT4 at the plasma 
membrane. The addition of sortilin to the cells increases the insulin stimulated 
plasma membrane staining but does not decrease the GLUT4 at the plasma 
membrane in the basal state. Another mechanism must exist to sequester 
GLUT4 from the plasma membrane in the absence of insulin. 
In order to develop insulin sensitivity at the level of mature adipocytes the 
cells must acquire a means to maintain GLUT4 intracellularly in the absence of 
insulin. Several candidate proteins exist that may be fulfilling this role. TUG 
interacts directly with GLUT4 and is necessary for efficient insulin-responsive 
glucose uptake in adipocytes (Bogan et al., 2003; Yu et al., 2007). It was thought 
that TUG may have a role in anchoring GLUT4 to intracellular compartments. 
This protein is present in both pre-adipocytes and adipocytes alike, and at similar 
levels (Figure 12). Despite the fact that TUG is present in pre-adipocytes, the 
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pre-adipocytes are unable to effectively sequester GLUT4 in a basal state, 
pointing to other mechanisms in play besides TUG alone.  
AS160, a Rab GTPase activating protein, is also shown to associate with 
IRVs but only in the basal state as it dissociates from the vesicle upon insulin 
stimulation (Larance et al., 2005; Peck et al., 2006). We examined our GS pre-
adipocytes for the expression of AS160 and found that though it is present in the 
pre-adipocyte, it is at about ¼ of the level that it is in the adipocyte (Figure 12). In 
wild-type and GS cells, AS160 is strongly induced around day 4 of differentiation 
(Figure 13 A-B). This induction occurs concurrently with sortilin induction, the 
formation of IRVs and the subsequent acquisition of insulin responsiveness.  
Knocking down AS160 in adipocytes has been previously shown to 
increase the levels of GLUT4 at the plasma membrane, though not to the level 
that the addition of insulin does (Brewer et al., 2011). To further characterize its 
role in GLUT4 translocation, we electroporated FLAG-tagged AS160 into pre-
adipocytes containing myc7-GLUT4 and sortilin-myc/His and examined the 
localization of GLUT4. These GS pre-adipocytes do form insulin responsive 
vesicles but as I showed earlier, they are unable to effectively sequester GLUT4. 
Upon the addition of WT AS160 or the phosphorylation mutant 6P, GLUT4 is 
maintained intracellularly in the absence of insulin (Figure 15). The addition of 
insulin shows effective translocation of GLUT4 and shows that our exogenous 
WT AS160 is phosphorylated as the wild type protein would be (Figure 16 and 
17). The expression of AS160 in addition to the existence of TUG allows the pre-
	  109 
adipocytes to effectively respond to insulin by tethering GLUT4 to a specialized 
compartment in the absence of insulin and allows them to respond to the 
stimulation by releasing GLUT4 to the plasma membrane. Based on 
immunoprecipitation and immunofluorescence evidence, it seems that wild-type 
or exogenously expressed AS160 does not interact with sortilin or GLUT4 
(Figures 14,18,19). 
B. CHAPTER 2  
1. ACSL-1 and fatty acid induced insulin resistance 
 ACSL-1 catalyzes the first step in the metabolism of long-chain fatty acids 
and has been shown to be important in maintaining the insulin sensitivity of 
adipocytes (Gao et al., 2004; Lobo et al., 2009). A previous lab member showed 
that saturated free fatty acids, namely palmitate, can decrease the levels of the 
insulin-sensitizing adipokine, adiponectin. The decrease in adiponectin is 
modulated via an ACSL-1-dependent mechanism (Karki et al., 2011). We further 
examined the mechanism by which saturated free fatty acids are able to induce 
insulin resistance. Our studies here show that incubating 3T3-L1 adipocytes with 
palmitate causes a decreased level of insulin signaling as measured by a 
decrease in the phosphorylation of Akt at threonine 308 and serine 473 (Figure 
20). The decrease in phosphorylation demonstrates a diminished ability to 
respond to insulin stimulation when palmitate is present. Palmitate also leads to a 
decrease in insulin-stimulated glucose uptake in adipocytes, showing that the 
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cells are less effective at clearing glucose in the presence of high levels of 
saturated free fatty acids as in cases of obesity (Figure 21).  
It is important to determine the mechanism of decreased adiponectin 
levels. Since the mechanism is ACSL-1-dependent, we utilized a cell line that 
has ACSL-1 knocked down by shRNA. By overexpressing sortilin on this 
knockdown background, we’ve shown that sortilin loses the perinuclear 
localization that it possesses in cells that still have ACSL-1 (Figure 22). This is 
not entirely surprising given that ACSL-1 is a binding partner of sortilin (Huang, 
2010). Losing this perinuclear localization could effectively blunt the ability of the 
cell to respond to insulin but more investigation needs to be done in this area.  
The formation of stress granules is a viable option for the decrease in 
adiponectin mRNA. These punctate cytoplasmic structures contain mRNA that is 
not being actively translated. Though stress granules had not been previously 
examined in 3T3-L1s we saw that they can be induced by sodium arsenite to the 
same extent as in mouse embryonic fibroblasts, an established model system 
(Figure 23). Since stress granules are sites of accumulation of stalled mRNAs 
and adiponectin mRNA is decreased upon incubation with palmitate, we 
examined how palmitate effected the formation of stress granules. Incubation 
with palmitic acid caused the formation of stress granules and this could 
potentially be the mechanism by which the adipocyte decreases adiponectin 
expression.  
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In these studies, we show that sortilin is conferring insulin responsiveness 
to the insulin responsive vesicle. Sortilin translocates to the plasma membrane in 
response to insulin and increases the insulin responsiveness of GLUT4 when it is 
co-transfected into pre-adipocytes. We’ve also expanded on the knowledge of 
AS160 by showing that its expression is sufficient to basally retain GLUT4 in the 
absence of insulin. This is an important mechanism that must be in place for the 
cells to achieve maximal insulin responsiveness.  
Another set of studies show fairly preliminary data relating the presence of 
free fatty acids to the development of insulin resistant characteristics. Palmitate 
can decrease insulin signaling, insulin-stimulated glucose uptake, and induce the 
formation of stress granules. Further examination of the stress granule formation 
may reveal interesting mechanisms in play for the decrease in insulin sensitizing 
adipokines like adiponectin. 
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